HERON THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.28
-5.67%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-21.9%
3 months
-45.6%
6 months
-78.1%
1 year
-75.6%
Year to date
-78.6%
52-week range
$0.27 – $1.49
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$52.8M
P/E
-1.6
P/B
7.6
P/S
0.3
Revenue
$151.18M
Net income
-$34.05M
Diluted EPS
-0.18
Gross margin
70.10%
Net margin
-22.50%
Return on equity
-300.90%
Total debt
$148.35M
Cash
$20.72M
Free cash flow
-$12.09M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $37.67M | -$5.49M | 69.30% | -14.60% | -$2.35M |
| Mar 31, 2026 | $34.71M | -$8.11M | 69.40% | -23.40% | -$1.93M |
| Dec 31, 2025 | $40.59M | -$2.95M | 72.60% | -7.30% | -$9.17M |
| Sep 30, 2025 | $38.21M | -$17.5M | 68.80% | -45.80% | $1.36M |
| Jun 30, 2025 | $37.2M | -$2.38M | 73.50% | -6.40% | -$11.07M |
| Mar 31, 2025 | $38.9M | $2.64M | 78.30% | 6.80% | -$8.94M |
| Dec 31, 2024 | $40.78M | $3.66M | 74.90% | 9.00% | -$12.39M |
| Sep 30, 2024 | $32.81M | -$4.85M | 71.20% | -14.80% | $2.94M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent HRTX news
All market newsNo ticker-linked stories are in the current archive.